ProfileGDS4718 / 227565_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 32% 94% 21% 40% 64% 40% 24% 33% 34% 29% 50% 17% 40% 25% 55% 37% 44% 47% 53% 17% 23% 40% 31% 35% 34% 38% 34% 19% 17% 61% 74% 30% 36% 46% 56% 31% 27% 37% 93% 36% 26% 68% 56% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2741323
GSM549102patient 115, normal, homogenized [OPG study]4.6213532
GSM549104patient 119, normal, homogenized [OPG study]9.9278994
GSM549108patient 138, normal, homogenized [OPG study]4.2333321
GSM549119patient 077, normal, homogenized [OPG study]4.9923240
GSM549133patient 032, cancer, homogenized [OPG study]6.4511364
GSM549139patient 042, cancer, homogenized [OPG study]4.9560240
GSM549099patient 107, normal, homogenized [OPG study]4.3161124
GSM549109patient 139, normal, homogenized [OPG study]4.6984233
GSM549110patient 046, normal, homogenized [OPG study]4.6946434
GSM549114patient 063, normal, homogenized [OPG study]4.4455929
GSM549122patient 082, normal, homogenized [OPG study]5.4930550
GSM549134patient 033, cancer, homogenized [OPG study]4.0297717
GSM549136patient 036, cancer, homogenized [OPG study]4.9344540
GSM549140patient 044, cancer, homogenized [OPG study]4.2924925
GSM549111patient 047, normal, homogenized [OPG study]5.8038955
GSM549113patient 057, normal, homogenized [OPG study]4.7974637
GSM549132patient 031, cancer, homogenized [OPG study]5.2016544
GSM549137patient 038, cancer, homogenized [OPG study]5.3216247
GSM549142patient 047, cancer, homogenized [OPG study]5.8385953
GSM549100patient 110, normal, homogenized [OPG study]4.0277117
GSM549107patient 135, normal, homogenized [OPG study]4.2438923
GSM549115patient 068, normal, homogenized [OPG study]4.9151140
GSM549116patient 072, normal, homogenized [OPG study]4.5482531
GSM549120patient 078, normal, homogenized [OPG study]4.756935
GSM549131patient 030, cancer, homogenized [OPG study]4.6389134
GSM549118patient 074, normal, homogenized [OPG study]4.9106538
GSM549129patient 027, cancer, homogenized [OPG study]4.7497834
GSM549123patient 088, normal, homogenized [OPG study]4.1015919
GSM549124patient 006, cancer, homogenized [OPG study]4.0814217
GSM549126patient 015, cancer, homogenized [OPG study]6.1898461
GSM549128patient 025, cancer, homogenized [OPG study]7.3633674
GSM549103patient 117, normal, homogenized [OPG study]4.6108130
GSM549117patient 073, normal, homogenized [OPG study]4.775136
GSM549138patient 041, cancer, homogenized [OPG study]5.2894346
GSM549141patient 045, cancer, homogenized [OPG study]5.8726656
GSM549130patient 028, cancer, homogenized [OPG study]4.5995331
GSM549101patient 111, normal, homogenized [OPG study]4.4352327
GSM549105patient 128, normal, homogenized [OPG study]4.8626637
GSM549106patient 134, normal, homogenized [OPG study]9.9283293
GSM549112patient 048, normal, homogenized [OPG study]4.817636
GSM549125patient 011, cancer, homogenized [OPG study]4.3734526
GSM549127patient 024, cancer, homogenized [OPG study]6.8146968
GSM549135patient 035, cancer, homogenized [OPG study]5.8227256